Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301

K-Number: K072113 · 2007-10-10

ApplicantIntegra Lifesciences Corp.
Decision Date2007-10-10
Product CodeKGN
DecisionSubstantially Equivalent

Device Summary

INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301 is the device name listed in this FDA 510(k) record. The listed applicant is Integra Lifesciences Corp.. It received FDA 510(k) clearance on 2007-10-10 under 510(k) number K072113. The device is classified under product code KGN. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301?

INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301 is a medical device that received FDA 510(k) clearance on 2007-10-10. The listed applicant is Integra Lifesciences Corp.. The 510(k) number is K072113.

When did INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301 receive FDA 510(k) clearance?

INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301 received FDA 510(k) clearance on 2007-10-10, under 510(k) number K072113.

Who is the listed applicant for INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301?

The FDA 510(k) record lists Integra Lifesciences Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301?

The FDA product code for INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301 is KGN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Integra Lifesciences Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K183581Codman Disposable PerforatorsK183406CereLink ICP Monitor, CereLink ICP Extension CableK182265CodMan Certas Plus Programmable ValveK181902Codman Certas Plus Electronic Tool KitK131184INTEGRA LICOX PTO2 MONITORK092227JARIT, RUGGLES, R&B REDMOND/ REDMOND, MILTEX, MEISTERHAND - KERRISON RONGEURS

View all 27 devices →

Related Devices (Code: KGN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260652ColActive PlusCovalon Technologies, Ltd.K260711Accelagen Plus Surgical Matrix, 1cc (CG-01AP);Accelagen Plus Surgical Matrix, 3cc (CG-03AP);Accelagen Plus Surgical Matrix, 5cc (CG-05AP);Accelagen Plus Surgical Strip, 125x25x2mm (CG-125X25AP);Accelagen Plus Surgical Strip, 250x25x2mm (CG-250X25AP)Berkeley Advanced BiomaterialsK260596Collagen Wound PowderVentris MedicalK260669Endoform Dermal TemplateAroa Biosurgery , Ltd.K253521ECMT-100 WMDEcm Therapeutics, Inc.K253204CatalyzeBioTissue Holdings, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑